JMIR AI · 2026-11-03 · 期刊论文
Abstract Background Repurposing approved drugs offers a time- and cost-effective alternative to traditional drug development. However, in silico prediction of repurposing candidates is challenging and requires the effective collaboration of specialists in various fields, including pharmacology, medicine, biology, and bioinformatics. Fragmented, specialized algorithms and tools often address only narrow aspects of the…
(中文解读待补写)
🔗 打开原文
Simon Süwer, Kester Bagemihl, Sylvie Baier 等
本文摘自《每日前沿研究简报 · 2026-11-05》「信息科学」。本内容仅用于研究信息整理与科普交流,不构成医疗建议。

发表评论 取消回复